Retatrutide 15MG
$110.00
Retatrutide 15MG is a 15-milligram format of retatrutide, a synthetic peptide investigated as a multi receptor agonist in metabolic research. Studies have examined retatrutide in the context of incretin and glucagon signaling pathways, including receptor activity linked to energy balance. Researchers commonly use it in controlled laboratory settings where peptide receptor pharmacology is evaluated.
In Stock
Retatrutide 15MG is a 15-milligram format of retatrutide, a synthetic multi receptor peptide agonist studied in metabolic and endocrine research. Retatrutide 15MG is of interest in experiments that examine peptide driven signaling across incretin and glucagon related receptors, with outcomes assessed using in vitro assays and preclinical models.
Because it is designed to engage more than one receptor class, retatrutide has been investigated for how combined receptor agonism may influence measurable biomarkers in laboratory systems. Research teams may also study its receptor selectivity, potency, and downstream pathway activation using standardized pharmacology methods.
- Specification: 15MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Trenbolone Acetate 75Mg, Trenbolone Enanthate 125Mg – 200mg/ml, 10 ml is a combined format of trenbolone in two ester forms: acetate and enanthate. Trenbolone is a synthetic anabolic androgenic steroid derived from 19-nortestosterone and widely referenced in endocrine and receptor binding research. Studies have examined esterified trenbolone in the context of androgen receptor signaling, pharmacokinetics, and steroid structure activity relationships.
In Stock
Trenbolone Enanthate 250Mg; Drostanolone Enanthate 250Mg – 500mg/ml, 10ml is a combined format of two anabolic androgenic steroid esters: trenbolone (a 19 nor testosterone derivative) and drostanolone (a DHT derived analogue). Researchers may reference these compounds in studies involving androgen receptor signaling, esterified steroid pharmacokinetics, and analytical method development. Work in the literature commonly discusses trenbolone and drostanolone in the context of endocrine pathways and structure activity relationships.
In Stock
Masteron Blend Drostanolone Enanthate 150Mg / Drostanolone Propionate 50Mg 200mg/ml 10 ml is a specified blend of two drostanolone esters in a 10 ml format at 200 mg per ml total concentration. Drostanolone is a synthetic androgen derived from dihydrotestosterone that is studied in androgen receptor and steroid ester pharmacology research. Work in analytical settings commonly examines ester composition, stability, and identity using chromatographic and mass spectrometry methods.
In Stock
Masteron / Drostanolone Propionate 100mg/ml 10ml is a preparation of drostanolone propionate, an androgenic anabolic steroid derived from dihydrotestosterone. Researchers may reference drostanolone in studies involving androgen receptor signaling and steroid structure activity relationships. It is also encountered in analytical work focused on identification, profiling, and method development for anabolic agents.
In Stock
Semaglutide 10MG is a 10-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. Researchers study semaglutide in receptor pharmacology and metabolic signaling research, including models examining appetite regulation and glucose homeostasis. It is also used in assay development and method validation where GLP 1 pathway engagement is of interest.
In Stock
Trenbolone Base 50mg ml 10ml refers to trenbolone in a 50 mg per mL concentration across a 10 mL format. Trenbolone is a synthetic anabolic androgenic steroid derived from the 19 nor testosterone scaffold. Researchers have used trenbolone as a reference compound in studies involving androgen receptor signaling and anabolic steroid structure activity relationships.
In Stock
Winstrol 50mg ml 10ml refers to stanozolol at a labeled concentration of 50 mg per mL in a 10 mL format. Stanozolol is a synthetic anabolic androgenic steroid derived from dihydrotestosterone, commonly referenced in analytical and sports doping research. Researchers may examine it in studies involving androgen receptor signaling, steroid metabolism, and assay validation.
In Stock
Tirzepatide 20MG is a 20-milligram format of tirzepatide, a synthetic peptide studied as a dual GIP and GLP 1 receptor agonist. Researchers examine tirzepatide in metabolic research, including models related to glycemic regulation, appetite signaling, and energy balance.
In Stock
Tirzepatide 10MG is a 10-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glycemic physiology, and energy balance pathways.
In Stock
Trenbolone Acetate 100Mg; Drostanolone Propionate 100Mg; Testosterone Propionate 100Mg – 300mg/ml, 10ml is a multi compound anabolic androgenic steroid blend specified at 300mg/ml in a 10ml format. Trenbolone acetate is a 19 nor testosterone derivative, while drostanolone and testosterone propionate are DHT derived and testosterone based esters used in androgen research. Researchers may examine combined esterified androgens in models involving receptor binding, anabolic androgenic signaling, and pharmacokinetic comparisons.
In Stock
Semaglutide 20MG is a 20 milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is a 31 amino acid peptide modified for extended stability, and it is widely used in laboratory work involving incretin signaling and metabolic regulation. Researchers study semaglutide in preclinical and translational settings related to glucose homeostasis, appetite pathways, and receptor pharmacology.
In Stock
Cagrilintide + Semaglutide 5MG is a 5-milligram combined format of two peptide research compounds: cagrilintide (an amylin analogue) and semaglutide (a GLP 1 receptor agonist peptide analogue). Researchers study this pairing in preclinical and clinical research settings focused on appetite regulation and metabolic signaling. Studies have examined how amylin and GLP 1 pathways may interact when investigated together.
In Stock
